The Investor's DNA - Impacting Biomedical Startups through Venture Capital

The Investor's DNA - Impacting Biomedical Startups through Venture Capital - Hardcover

$28.80
Sale price  $28.80 Regular price 
Skip to product information
The Investor's DNA - Impacting Biomedical Startups through Venture Capital

The Investor's DNA - Impacting Biomedical Startups through Venture Capital - Hardcover

$28.80
Sale price  $28.80 Regular price 

Reliable shipping

Flexible returns

by Anand Govindaluri (Author)

This book traces Anand Govindaluri's journey from biotech researcher to global biomedical venture capitalist. This work discusses the courage to take calculated risks in biomedical investments, drawing on real experiences. It highlights successes and failures, offers insights into venture capital decisions, and presents strategies for effective investment, including international GEM leadership perspectives in pharma, medtech, and digital health. Contributing leaders to this book are:

Goran S Malm, Former President, Dell Corp Asia Pacific & GE Medical Systems Asia

D A Prasanna, Chief Patron, Prasanna School of Public Health, Manipal, Author-Innovate Locally to Win Globally, Former MD & CEO, WiproGE India

C P Bothra, Chairman, Lyrus Life Sciences, India & Former MD, Medreich, India

Gourab Mukherjee, Co-Founder & CEO, Aktivolabs, Singapore

Patti White, CEO, and Peter Galen, CIO, Hemex Health Inc, USA

Number of Pages: 228
Dimensions: 0.69 x 8.5 x 5.5 IN
Publication Date: August 23, 2025

You may also like